Report cover image

Cell Based Assays Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Publisher Persistence Research & Consultancy Services
Published Apr 03, 2026
Length 176 Pages
SKU # PERR21067737

Description

Persistence Market Research has recently released a comprehensive report on the global Cell-based Assays Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:
  • Cell-based Assays Market Size (2025E): US$ 18.4 Bn
  • Projected Market Value (2032F): US$ 33.3 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.9%
Cell-based Assays Market - Report Scope:

The cell-based assays market encompasses a wide range of laboratory techniques used to study cellular responses in controlled environments, primarily for drug discovery, toxicity testing, and biological research. These assays utilize living cells to evaluate biological activity, offering more physiologically relevant insights compared to traditional biochemical assays. The market includes a variety of products and services such as reagents, assay kits, microplates, probes and labels, instruments, software, and different types of cell lines. The increasing prevalence of complex diseases, combined with regulatory encouragement for human-relevant testing models, is significantly driving the adoption of cell-based assays. Additionally, the growing need for reproducible workflows and efficient drug screening processes is further supporting market expansion across pharmaceutical, biotechnology, and research institutions.

Market Growth Drivers:

The growth of the global cell-based assays market is primarily driven by the rising prevalence of complex diseases such as cancer, neurological disorders, and chronic conditions, which require advanced and accurate research models for drug development. Increasing regulatory emphasis on reducing animal testing and promoting human-relevant in vitro models has accelerated the adoption of cell-based assays across pharmaceutical and biotechnology companies. The growing demand for reproducible and high-throughput screening workflows in drug discovery processes is further fueling market growth. Additionally, technological advancements in cell biology, assay development, and automation are enhancing the efficiency and reliability of cell-based assays, contributing to their widespread utilization in research and development activities.

Market Restraints:

Despite strong growth potential, the cell-based assays market faces several challenges that may limit its expansion. High costs associated with advanced assay technologies, instruments, and specialized reagents can restrict adoption, particularly among smaller research organizations. Technical complexities involved in maintaining cell cultures and ensuring reproducibility across experiments can also pose operational challenges. Variability in cell line performance and sensitivity to environmental conditions may impact assay outcomes and reliability. Furthermore, stringent regulatory requirements and validation processes for new assay methods can increase time-to-market and development costs for manufacturers.

Market Opportunities:

The cell-based assays market presents significant growth opportunities driven by continuous advancements in biotechnology and drug discovery processes. Increasing investments in personalized medicine and targeted therapies are creating demand for more precise and predictive cell-based models. The expansion of contract research organizations (CROs) and outsourcing of drug discovery activities offer new avenues for market growth. Emerging technologies such as 3D cell cultures, organ-on-chip systems, and stem cell-based assays are expected to revolutionize the field and open new application areas. Additionally, growing research activities in emerging regions and increasing collaborations between academic institutions and industry players are likely to further accelerate market expansion.

Key Questions Answered in the Report:
  • What are the primary factors driving the global cell-based assays market's growth?
  • Which regions and market segments are experiencing the highest demand for cell-based assays?
  • How are technological advancements influencing assay development and adoption?
  • Who are the key players in the cell-based assays market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global cell-based assays market?
Competitive Intelligence and Business Strategy:

Leading companies in the global cell-based assays market are focusing on product innovation, advanced assay technologies, and strategic collaborations to strengthen their market position. These companies are investing in research and development to improve assay sensitivity, reproducibility, and efficiency. Expanding product portfolios to include advanced cell lines, assay kits, and automation solutions is a key strategy adopted by market players. Additionally, partnerships with pharmaceutical companies, academic institutions, and contract research organizations are helping expand market reach. Emphasis on high-throughput screening technologies and integration of digital tools further supports competitive differentiation.

Companies Covered in This Report:
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Corning Incorporated
  • Becton, Dickinson and Company (BD)
  • Charles River Laboratories
  • Lonza Group AG
  • F. Hoffmann-La Roche Ltd. (Roche Holdings AG)
  • Danaher Corporation
  • Perkin Elmer Inc.
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
Market Segmentation

By Products and Services
  • Reagents
  • Assay Kits
  • Cell Growth Assays
  • Reporter Gene Assays
  • Cell Death Assays
  • Second Messenger Assays
  • Microplates
  • Probes and Labels
  • Instruments and Software
  • Cell Lines
  • Primary Cell Lines
  • Stem Cell Lines
  • Immortalized Cell Lines
By Application
  • Basic Research
  • Drug Discovery
  • Others
By End-user
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
By Region
  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

176 Pages
1. Executive Summary
1.1. Global Cell-based Assays Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Chain Analysis
3.1. Supply Chain Analysis
3.2. List of Key Market Players
4. Value Added Insights
4.1. PESTLE Analysis
4.2. Porter’s Five Force Analysis
5. Price Trend Analysis, 2019 - 2032
5.1. Pricing Analysis, By Products and Services
5.2. Key Factors Impacting Prices, By Application
6. Global Cell-based Assays Market Outlook
6.1. Key Highlights
6.1.1. Market Size (US$ Bn) and Y-o-Y Growth
6.1.2. Absolute $ Opportunity
6.2. Market Size (US$ Bn) Analysis and Forecast
6.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
6.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
6.3. Global Cell-based Assays Market Outlook: Products and Services
6.3.1. Historical Market Size (US$ Bn) Analysis, By Products and Services, 2019-2024
6.3.2. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
6.3.2.1. Reagents
6.3.2.2. Assay Kits
6.3.2.2.1. Cell Growth Assays
6.3.2.2.2. Reporter Gene Assays
6.3.2.2.3. Cell Death Assays
6.3.2.2.4. Second Messenger Assays
6.3.2.3. Microplates
6.3.2.4. Probes and Labels
6.3.2.5. Instruments and Software
6.3.2.6. Cell Lines
6.3.2.6.1. Primary Cell Lines
6.3.2.6.2. Stem Cell Lines
6.3.2.6.3. Immortalized Cell Lines
6.3.3. Market Attractiveness Analysis: Products and Services
6.4. Global Cell-based Assays Market Outlook: Application
6.4.1. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
6.4.2. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
6.4.2.1. Basic Research
6.4.2.2. Drug Discovery
6.4.2.3. Others
6.4.3. Market Attractiveness Analysis: Application
6.5. Global Cell-based Assays Market Outlook: End-user
6.5.1. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
6.5.2. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
6.5.2.1. Pharmaceutical and Biotechnology Companies
6.5.2.2. Academic and Research Institutes
6.5.2.3. Contract Research Organizations (CROs)
6.5.3. Market Attractiveness Analysis: End-user
7. Global Cell-based Assays Market Outlook: Region
7.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
7.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
7.2.1. North America
7.2.2. Europe
7.2.3. East Asia
7.2.4. South Asia and Oceania
7.2.5. Latin America
7.2.6. Middle East & Africa
7.3. Market Attractiveness Analysis: Region
8. North America Cell-based Assays Market Outlook
8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Products and Services
8.1.3. By Application
8.1.4. By End-user
8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.2.1. U.S.
8.2.2. Canada
8.3. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
8.3.1. Reagents
8.3.2. Assay Kits
8.3.2.1. Cell Growth Assays
8.3.2.2. Reporter Gene Assays
8.3.2.3. Cell Death Assays
8.3.2.4. Second Messenger Assays
8.3.3. Microplates
8.3.4. Probes and Labels
8.3.5. Instruments and Software
8.3.6. Cell Lines
8.3.6.1. Primary Cell Lines
8.3.6.2. Stem Cell Lines
8.3.6.3. Immortalized Cell Lines
8.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
8.4.1. Basic Research
8.4.2. Drug Discovery
8.4.3. Others
8.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
8.5.1. Pharmaceutical and Biotechnology Companies
8.5.2. Academic and Research Institutes
8.5.3. Contract Research Organizations (CROs)
8.6. Market Attractiveness Analysis
9. Europe Cell-based Assays Market Outlook
9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Products and Services
9.1.3. By Application
9.1.4. By End-user
9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Turkey
9.2.8. Rest of Europe
9.3. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
9.3.1. Reagents
9.3.2. Assay Kits
9.3.2.1. Cell Growth Assays
9.3.2.2. Reporter Gene Assays
9.3.2.3. Cell Death Assays
9.3.2.4. Second Messenger Assays
9.3.3. Microplates
9.3.4. Probes and Labels
9.3.5. Instruments and Software
9.3.6. Cell Lines
9.3.6.1. Primary Cell Lines
9.3.6.2. Stem Cell Lines
9.3.6.3. Immortalized Cell Lines
9.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
9.4.1. Basic Research
9.4.2. Drug Discovery
9.4.3. Others
9.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
9.5.1. Pharmaceutical and Biotechnology Companies
9.5.2. Academic and Research Institutes
9.5.3. Contract Research Organizations (CROs)
9.6. Market Attractiveness Analysis
10. East Asia Cell-based Assays Market Outlook
10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Products and Services
10.1.3. By Application
10.1.4. By End-user
10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.3. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
10.3.1. Reagents
10.3.2. Assay Kits
10.3.2.1. Cell Growth Assays
10.3.2.2. Reporter Gene Assays
10.3.2.3. Cell Death Assays
10.3.2.4. Second Messenger Assays
10.3.3. Microplates
10.3.4. Probes and Labels
10.3.5. Instruments and Software
10.3.6. Cell Lines
10.3.6.1. Primary Cell Lines
10.3.6.2. Stem Cell Lines
10.3.6.3. Immortalized Cell Lines
10.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
10.4.1. Basic Research
10.4.2. Drug Discovery
10.4.3. Others
10.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
10.5.1. Pharmaceutical and Biotechnology Companies
10.5.2. Academic and Research Institutes
10.5.3. Contract Research Organizations (CROs)
10.6. Market Attractiveness Analysis
11. South Asia & Oceania Cell-based Assays Market Outlook
11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Products and Services
11.1.3. By Application
11.1.4. By End-user
11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.2.1. India
11.2.2. Southeast Asia
11.2.3. ANZ
11.2.4. Rest of South Asia & Oceania
11.3. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
11.3.1. Reagents
11.3.2. Assay Kits
11.3.2.1. Cell Growth Assays
11.3.2.2. Reporter Gene Assays
11.3.2.3. Cell Death Assays
11.3.2.4. Second Messenger Assays
11.3.3. Microplates
11.3.4. Probes and Labels
11.3.5. Instruments and Software
11.3.6. Cell Lines
11.3.6.1. Primary Cell Lines
11.3.6.2. Stem Cell Lines
11.3.6.3. Immortalized Cell Lines
11.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
11.4.1. Basic Research
11.4.2. Drug Discovery
11.4.3. Others
11.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
11.5.1. Pharmaceutical and Biotechnology Companies
11.5.2. Academic and Research Institutes
11.5.3. Contract Research Organizations (CROs)
11.6. Market Attractiveness Analysis
12. Latin America Cell-based Assays Market Outlook
12.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.1.1. By Country
12.1.2. By Products and Services
12.1.3. By Application
12.1.4. By End-user
12.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.2.1. Brazil
12.2.2. Mexico
12.2.3. Rest of Latin America
12.3. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
12.3.1. Reagents
12.3.2. Assay Kits
12.3.2.1. Cell Growth Assays
12.3.2.2. Reporter Gene Assays
12.3.2.3. Cell Death Assays
12.3.2.4. Second Messenger Assays
12.3.3. Microplates
12.3.4. Probes and Labels
12.3.5. Instruments and Software
12.3.6. Cell Lines
12.3.6.1. Primary Cell Lines
12.3.6.2. Stem Cell Lines
12.3.6.3. Immortalized Cell Lines
12.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
12.4.1. Basic Research
12.4.2. Drug Discovery
12.4.3. Others
12.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
12.5.1. Pharmaceutical and Biotechnology Companies
12.5.2. Academic and Research Institutes
12.5.3. Contract Research Organizations (CROs)
12.6. Market Attractiveness Analysis
13. Middle East & Africa Cell-based Assays Market Outlook
13.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
13.1.1. By Country
13.1.2. By Products and Services
13.1.3. By Application
13.1.4. By End-user
13.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
13.2.1. GCC Countries
13.2.2. Egypt
13.2.3. South Africa
13.2.4. Northern Africa
13.2.5. Rest of Middle East & Africa
13.3. Market Size (US$ Bn) Analysis and Forecast, By Products and Services, 2025-2032
13.3.1. Reagents
13.3.2. Assay Kits
13.3.2.1. Cell Growth Assays
13.3.2.2. Reporter Gene Assays
13.3.2.3. Cell Death Assays
13.3.2.4. Second Messenger Assays
13.3.3. Microplates
13.3.4. Probes and Labels
13.3.5. Instruments and Software
13.3.6. Cell Lines
13.3.6.1. Primary Cell Lines
13.3.6.2. Stem Cell Lines
13.3.6.3. Immortalized Cell Lines
13.4. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
13.4.1. Basic Research
13.4.2. Drug Discovery
13.4.3. Others
13.5. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
13.5.1. Pharmaceutical and Biotechnology Companies
13.5.2. Academic and Research Institutes
13.5.3. Contract Research Organizations (CROs)
13.6. Market Attractiveness Analysis
14. Competition Landscape
14.1. Market Share Analysis, 2025
14.2. Market Structure
14.2.1. Competition Intensity Mapping By Market
14.2.2. Competition Dashboard
14.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
14.3.1. Bio-Rad Laboratories, Inc.
14.3.1.1. Overview
14.3.1.2. Segments and Products and Services
14.3.1.3. Key Financials
14.3.1.4. Market Developments
14.3.1.5. Market Strategy
14.3.2. Merck KGaA
14.3.3. Corning Incorporated
14.3.4. Becton, Dickinson and Company (BD)
14.3.5. Charles River Laboratories
14.3.6. Lonza Group AG
14.3.7. F. Hoffmann-La Roche Ltd. (Roche Holdings AG)
14.3.8. Danaher Corporation
14.3.9. Perkin Elmer Inc.
14.3.10. Thermo Fisher Scientific Inc.
14.3.11. Promega Corporation
15. Appendix
15.1. Research Methodology
15.2. Research Assumptions
15.3. Acronyms and Abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us